Codexis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Codexis and other ETFs, options, and stocks.

About CDXS

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. 

CEO
Alison Moore
CEOAlison Moore
Employees
146
Employees146
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2002
Founded2002
Employees
146
Employees146

CDXS Key Statistics

Market cap
182.33M
Market cap182.33M
Price-Earnings ratio
-4.92
Price-Earnings ratio-4.92
Dividend yield
Dividend yield
Average volume
1.38M
Average volume1.38M
High today
$1.70
High today$1.70
Low today
$1.58
Low today$1.58
Open price
$1.60
Open price$1.60
Volume
1.25M
Volume1.25M
52 Week high
$3.06
52 Week high$3.06
52 Week low
$0.9583
52 Week low$0.9583

Stock Snapshot

As of today, Codexis(CDXS) shares are valued at $1.67. The company's market cap stands at 182.33M, with a P/E ratio of -4.92.

On 2026-08-22, Codexis(CDXS) stock traded between a low of $1.58 and a high of $1.70. Shares are currently priced at $1.67, which is +6.0% above the low and -1.5% below the high.

The Codexis(CDXS)'s current trading volume is 1.25M, compared to an average daily volume of 1.38M.

In the last year, Codexis(CDXS) shares hit a 52-week high of $3.06 and a 52-week low of $0.96.

In the last year, Codexis(CDXS) shares hit a 52-week high of $3.06 and a 52-week low of $0.96.

CDXS News

TipRanks 3d
Codexis Earnings Call: Margin Gains, Scale-Up Bets

Codexis ((CDXS)) has held its Q2 earnings call. Read on for the main highlights of the call. Summer Sale - Claim 70% Off TipRanks Unlock powerful investing tool...

Nasdaq 4d
Codexis Q2 2026 Earnings Call Transcript

Codexis (CDXS) Q2 2026 Earnings Call Transcript The Motley Fool Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a mult...

Codexis Q2 2026 Earnings Call Transcript
TipRanks 5d
Codexis reports Q2 EPS (13c), consensus (12c)

Reports Q2 revenue $14.92M, consensus $13.82M. “I am pleased with the strong financial results reported today for the second quarter of 2026,” stated Alison Moo...

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%

More CDXS News

TipRanks 5d
Codexis price target lowered to $8 from $9 at Piper Sandler

Piper Sandler lowered the firm’s price target on Codexis (CDXS) to $8 from $9 and keeps an Overweight rating on the shares following quarterly results. The firm...

People also own

Based on the portfolios of people who own CDXS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.